<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055E428B-EF35-46E3-83A6-4D4004294C32"><gtr:id>055E428B-EF35-46E3-83A6-4D4004294C32</gtr:id><gtr:name>University of Utah</gtr:name><gtr:address><gtr:line1>201 South Presidents Circle</gtr:line1><gtr:line2>Salt Lake City</gtr:line2><gtr:line4>Utah</gtr:line4><gtr:postCode>UT 84112</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055E428B-EF35-46E3-83A6-4D4004294C32"><gtr:id>055E428B-EF35-46E3-83A6-4D4004294C32</gtr:id><gtr:name>University of Utah</gtr:name><gtr:address><gtr:line1>201 South Presidents Circle</gtr:line1><gtr:line2>Salt Lake City</gtr:line2><gtr:line4>Utah</gtr:line4><gtr:postCode>UT 84112</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/31904A8F-44F4-46CC-A53F-F896D3AB31F2"><gtr:id>31904A8F-44F4-46CC-A53F-F896D3AB31F2</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Curtis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15026"><gtr:id>8E05108B-E3E9-41AA-8FC9-43D850012D37</gtr:id><gtr:title>COMP-Ang1: Vascular Normalization and Neuroprotection for Diabetic Retinopathy</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15026</gtr:grantReference><gtr:abstractText>The goal of this project is development of a novel therapeutic, called COMP-Ang1, to promote vascular normalization and neuroprotection to treat diabetic retinal ischemia</gtr:abstractText><gtr:technicalSummary>The goal of this project is to effectively prevent progression of diabetic retinopathy (DR). Diabetic hyperglycemia is toxic to the retinal microvasculature, causing pericyte apoptosis, which in turn disrupts microvascular intracellular trafficking of the adherent cadherin:catenin (e.g., VE-cadherin) components of retinal vascular endothelial cell-cell junctions. While the pathogenesis of DR is complex with a variety of interlacing signals, systems and mechanisms, blood-retinal barrier dysfunction is a key element, as multiple growth factors and cytokines promote dissolution of cell-junctions, disrupting cell-cel contact and junctional integrity, leading to leakage, migration, and proliferation of microvascular endothelial cells. DR derives in large part from this vascular-destabilization process, resulting i an inflammatory milieu, angiogenesis, edema, neuronal loss, and gliosis. Our central hypothesis is that long-term gene delivery of COMP-Ang1 (angiopoietin-1 combined with the short coiled-coil domain of cartilage oligomeric matrix protein) has efficacy in promoting vascular normalization and neuroprotection in the presence of retinal ischemia. These experiments will elucidate the mechanisms underlying the vascular normalizing and neuroprotective capabilities of COMP-Ang1, define methods for optimizing the formulation of AAV.COMP-Ang1 gene delivery to the retina, particularly within the context of DR, and establish whether COMP-Ang1 promotes vascular regeneration by enhancing endothelial progenitor cell integration and vascular repair. Further, this project will enhance our understanding of the underlying mechanisms of DR. The Specific Aims are to determine whether: 1. Broadening tropism of AAV.COMP-Ang1 improves its retinal delivery 2. COMP-Ang1 has an ameliorative impact on intracellular mechanisms of diabetic retinal inflammation, endothelial flow responsiveness, and neuronal retinal dysfunction 3. COMP-Ang1 improves neurovascular structure and function in diabetic retinopathy 4. Constitutive expression of COMP-Ang1 enhances endothelial progenitor cell (EPC) integration in diabetic retinal vasculature This proposal is being submitted under the US-Ireland R&amp;amp;D Partnership Programme, and brings together investigators from the Moran Eye Center (University of Utah, US), the School of Biotechnology (Dublin City University, Republic of Ireland) and the Centre for Experimental Medicine (Queen's University of Belfast, Northern Ireland). The project fulfills the requirements of the US-Ireland R&amp;amp;D Partnership Programme by increasing the level of collaborative R&amp;amp;D amongst researchers across the three nations in an area focused on the development of new therapeutic approaches for enhancing disease prevention and healthcare. Funding for the proposed work in Dublin and Belfast will come from the Republic of Ireland (Science Foundation Ireland) and Northern Ireland (R&amp;amp;D Office), respectively. NIH funding is requested for the US component.</gtr:technicalSummary><gtr:fund><gtr:end>2019-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>150000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Utah</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Ophthalmology &amp; Visual Sciences</gtr:department><gtr:description>Viral delivery of COMP-ANG1 as therapeutic avenue for diabetic retinopathy</gtr:description><gtr:id>3F83DD57-1E06-4B1E-A8A6-D4903C4D9357</gtr:id><gtr:impact>pAAV2.Comp-Ang1 plasmid, supplied by US collaborators was amplified, checked and packaged into AAV2.Comp-Ang1 virus particles.
Protocol to detect AAV2 shedding after intravitreal injection in diabetic mice.</gtr:impact><gtr:outcomeId>58a702165a03a7.23597933-1</gtr:outcomeId><gtr:partnerContribution>The Ambati Lab at the Moran Eye Institute, University of Utah started the line of research we are expanding in this collaboration. They found preliminary evidence of vasoprotective and neuroprotective effects of virally delivered Comp-Ang1 in a mouse model of diabetic retinopathy, prompting an in-depth investigation into the mechanism(s) of action of Comp-Ang1 in this model as well as efforts to maximize its effectiveness.</gtr:partnerContribution><gtr:piContribution>Our part of this multinational effort is focusing on Comp-Ang1 normalizing blood flow changes and enhancing vascular repair in murine models of diabetic retinopathy.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Work Experience Student (Mary Davidson)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6B816D67-652E-4ED4-AF14-AE4CD495A833</gtr:id><gtr:impact>Mary Davidson from Sullivan Upper School visited the laboratory to gain work experience in molecular biology techniques. She was particularly interested in our current studies around gene therapy for the prevention and treatment of diabetic retinopathy and plans to pursue a career in medicine.</gtr:impact><gtr:outcomeId>58a4493b936786.77182416</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Northern Ireland Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F3AAEDF9-FECC-4C17-A09A-DBCF14FBB6B0</gtr:id><gtr:impact>The Centre for Experimental Medicine hosted an event entitled 'Know Your Enemy: Disease-Focused Research at Queen's' as part of the Northern Ireland Science Festival. This admission-free, open-to-the public event showcased some of the ongoing areas of research within the Centre. Dr Curtis and Dr Barabas helped to run stands on 'Cardiovascular' and 'Eye' diseases, respectively, including activities such as measuring your own heart rate, modelling the heart, crawling through blood vessels, colour vision testing, histological imaging of diseased tissue and whole organ dissections.</gtr:impact><gtr:outcomeId>58a4542cdbe5e1.42503013</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.nisciencefestival.com/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ulster Museum - Science Uncovered</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BFE476B4-FEF9-4400-87A7-FFADAFE8A1F4</gtr:id><gtr:impact>Dr Peter Barabas and Mr Michael O'Hare from Dr Curtis' laboratory took part in 'Science Uncovered' which took place in the Ulster Museum on Friday 30th September as part of European Researchers Night. Peter and Michael hosted a stand showcasing the anatomy and physiology of the eye and discussed diseases afflicting the retina. The event had over 400 visitors. European Researcher's Night is a Europe-wide initiative, in which thousands of researchers all across Europe meet the public and share their work in a social
setting.</gtr:impact><gtr:outcomeId>58a450025a7006.20441112</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview (U105)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1DF9D78F-3CB6-46BA-AB93-6EFB8DE23EC4</gtr:id><gtr:impact>Dr Curtis gave a radio interview for U105 explaining the goals of the US-Ireland Partnership Programme Award.</gtr:impact><gtr:outcomeId>58a45792f15652.23780580</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release (US-Ireland Partnership Programme)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C7CDFA59-DAAA-444B-8789-FEE29922BBE7</gtr:id><gtr:impact>Press release for the US-Ireland Partnership Programme Award written together with the Communications Office at Queen's and the HSC R&amp;amp;D Office (Belfast). The press release was picked up by several media outlets including the Irish Times, Drug Target review and Diabetes Technology and Therapeutics. It was also distributed by Queen's via social media channels including Linkedin and Facebook.</gtr:impact><gtr:outcomeId>58a45a5ed031b9.54572609</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Summer Studentship (Victoria Kosyak;Taras Shevchenko National University, Ukraine)</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Physiological Society</gtr:fundingOrg><gtr:id>61A181BF-18E8-48C4-B8FD-54B671CF5EED</gtr:id><gtr:outcomeId>58a31177c3de91.51191599</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Evaluation of CAMKII as a therapeutic target for diabetic macular oedema</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>12F2CD1E-5A36-4F3E-8C28-9C590FAF2105</gtr:id><gtr:outcomeId>58a300d5ddea47.03747450</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Summer Studentship (Sarah Hill; University College Dublin)</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Queen's University Belfast</gtr:fundingOrg><gtr:id>22C3D0EA-CF74-4189-8875-DDD713FCC37D</gtr:id><gtr:outcomeId>58a311d959b184.52960838</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - Targeting TRPV1 channels for the restoration of microvascular barrier function in diabetes</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Department for the Economy, Northern Ireland</gtr:fundingOrg><gtr:id>D8B9BCB1-16F4-4DD8-8B20-6A21B7F207AD</gtr:id><gtr:outcomeId>58a3144706e1f7.68866656</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Sciences UG student (Andrew Kenny)</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Queen's University Belfast</gtr:fundingOrg><gtr:id>73D495AE-4C52-49F3-A0CE-D72FF3B67B0B</gtr:id><gtr:outcomeId>58a30fc3651630.11298405</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15026</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>